{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:17:07Z","timestamp":1788499027949,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cellsig.2023.110866","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:27:45Z","timestamp":1692703665000},"page":"110866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation"],"prefix":"10.1016","volume":"111","author":[{"given":"Yingming","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10251","key":"10.1016\/j.cellsig.2023.110866_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110866_bb0010","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: a comprehensive review of current and future treatment","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110866_bb0015","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.cellsig.2023.110866_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110866_bb0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110866_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drup.2011.03.001","article-title":"Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways","volume":"14","author":"Rohwer","year":"2011","journal-title":"Drug Resist. Updat."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110866_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer","volume":"129","author":"Keith","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110866_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110866_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110866_bb0050","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cellsig.2023.110866_bb0055","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1172\/JCI137552","article-title":"HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer","volume":"130","author":"de Heer","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2023.110866_bb0060","first-page":"goac42","article-title":"The measurement and modification of hypoxia in colorectal cancer: overlooked but not forgotten","volume":"10","author":"Fletcher","year":"2022","journal-title":"Gastroenterol. Rep. (Oxf)"},{"issue":"11","key":"10.1016\/j.cellsig.2023.110866_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115703","article-title":"Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic","volume":"22","author":"Infantino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2023.110866_bb0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-030-34461-0_18","article-title":"Hypoxia compromises anti-cancer immune responses","volume":"1232","author":"Multhoff","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110866_bb0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","article-title":"The ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs) family","volume":"16","author":"Kelwick","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.cellsig.2023.110866_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.matbio.2018.06.002","article-title":"ADAMTS proteins in human disorders","volume":"71-72","author":"Mead","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.cellsig.2023.110866_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.matbio.2015.02.004","article-title":"ADAMTS proteases in vascular biology","volume":"44-46","author":"Rodr\u00edguez-Manzaneque","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.cellsig.2023.110866_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.matbio.2022.11.001","article-title":"ADAMTS6 cleaves the large latent TGF\u03b2 complex and increases the mechanotension of cells to activate TGF\u03b2","volume":"114","author":"Cain","year":"2022","journal-title":"Matrix Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110866_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10120-018-0866-2","article-title":"ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer","volume":"22","author":"Huang","year":"2019","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2023.110866_bb0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.118.313737","article-title":"The emerging role of the ADAMTS family in vascular diseases","volume":"123","author":"Rienks","year":"2018","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.cellsig.2023.110866_bb0105","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1007\/s00018-010-0431-6","article-title":"ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity","volume":"67","author":"Dubail","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110866_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/biom11040561","article-title":"ADAMTS19 suppresses cell migration and invasion by targeting S100A16 via the NF-\u03baB pathway in human gastric cancer","volume":"11","author":"Jiang","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110866_bb0115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10120-022-01319-4","article-title":"ADAMTS10 inhibits aggressiveness via JAK\/STAT\/c-MYC pathway and reprograms macrophage to create an anti-malignant microenvironment in gastric cancer","volume":"25","author":"Zhou","year":"2022","journal-title":"Gastric Cancer"},{"issue":"20","key":"10.1016\/j.cellsig.2023.110866_bb0120","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/onc.2010.49","article-title":"Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis","volume":"29","author":"El Hour","year":"2010","journal-title":"Oncogene"},{"issue":"Pt 16","key":"10.1016\/j.cellsig.2023.110866_bb0125","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1242\/jcs.050468","article-title":"The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer","volume":"122","author":"Moncada-Pazos","year":"2009","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110866_bb0130","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1038\/s41598-021-90330-3","article-title":"ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer","volume":"11","author":"Hou","year":"2021","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.cellsig.2023.110866_bb0135","article-title":"The novel protein ADAMTS16 promotes gastric carcinogenesis by targeting IFI27 through the NF-\u03bab signaling pathway","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.cellsig.2023.110866_bb0140","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110866_bb0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.trsl.2015.05.001","article-title":"Upregulation of a disintegrin and metalloprotease 8 is associated with progression and prognosis of patients with gastric cancer","volume":"166","author":"Huang","year":"2015","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110866_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ccr.2005.12.021","article-title":"ERK-MAPK signaling opposes rho-kinase to promote endothelial cell survival and sprouting during angiogenesis","volume":"9","author":"Mavria","year":"2006","journal-title":"Cancer Cell"},{"issue":"7649","key":"10.1016\/j.cellsig.2023.110866_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110866_bb0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110866_bb0165","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.immuni.2017.04.015","article-title":"CD4 + T cell activation and vascular normalization: two sides of the same coin?","volume":"46","author":"De Palma","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110866_bb0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.trecan.2018.02.010","article-title":"Reengineering the tumor vasculature: improving drug delivery and efficacy","volume":"4","author":"Stylianopoulos","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cellsig.2023.110866_bb0175","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1038\/ncomms16074","article-title":"Non-canonical NOTCH3 signalling limits tumour angiogenesis","volume":"8","author":"Lin","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110866_bb0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.21037\/atm.2020.02.154","article-title":"ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the Wnt\/\u03b2-catenin signaling pathway in vitro","volume":"8","author":"Li","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cellsig.2023.110866_bb0185","series-title":"Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF- \u03ba B Pathway in Human Gastric Cancer","author":"ADAMTS19","year":"2023"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110866_bb0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.21037\/atm.2020.02.154","article-title":"ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the","volume":"8","author":"Li","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110866_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050682","article-title":"ADAMTS-15 has a tumor suppressor role in prostate cancer","volume":"10","author":"Binder","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.cellsig.2023.110866_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.matbio.2015.03.007","article-title":"ADAMTS proteases in fertility","volume":"44-46","author":"Russell","year":"2015","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110866_bb0210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-020-01658-z","article-title":"TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1","volume":"39","author":"Pang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110866_bb0215","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41591-018-0023-9","article-title":"SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo","volume":"24","author":"Mainardi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2023.110866_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100822","article-title":"Targeting metabolism to overcome cancer drug resistance: a promising therapeutic strategy for diffuse large B cell lymphoma","volume":"61","author":"Pi","year":"2022","journal-title":"Drug Resist. Updat."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110866_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.194","article-title":"miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer","volume":"7","author":"Hu","year":"2016","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.cellsig.2023.110866_bb0230","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.7150\/thno.55074","article-title":"FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts","volume":"11","author":"Wan","year":"2021","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110866_bb0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","volume":"15","author":"Khan","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:12:15Z","timestamp":1760267535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823002802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"alternative-id":["S0898656823002802"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110866","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110866"}}